IRS Inversion Regs Don't Solve Tax Code Issues, Rep. Says
The Internal Revenue Service's recently proposed anti-inversion regulations, which led to the highly publicized death of the $160 billion Pfizer-Allergan merger, are only a bandage fix that fail to address why...To view the full article, register now.
Already a subscriber? Click here to view full article